| abstract |
A novel anticancer agent and a method for screening a new anticancer agent are provided. Contacting a cancer cell expressing a TACC3 protein with a candidate substance, measuring a ratio of mitotic cells in the cell contacted with the substance, and contacting the substance with the substance A method for screening an anticancer agent, comprising a step of measuring the expression or function of TACC3 protein in a cell. Selected from the group consisting of lymphoma, hemangiosarcoma, non-small cell lung cancer, breast cancer, gastrointestinal tumor and ovarian cancer, comprising shRNA or siRNA against TACC3 targeting at least one sequence selected from the group consisting of specific sequences An anticancer agent against at least one of the above. [Selection figure] None |